Target intelligence / Profile preview

Fusarium

Molecular classification
Filamentous fungus, Ascomycota, Pathogenic fungus, Mycotoxin producer
01

Overview

Fusarium is a diverse and widely distributed genus of filamentous fungi within the phylum Ascomycota, encompassing species that are significant pathogens for both plants and humans. In agricultural contexts, these fungi cause devastating crop diseases and produce harmful mycotoxins like fumonisins and trichothecenes, which can contaminate food supplies and cause acute or chronic toxicosis. In clinical medicine, Fusarium species cause opportunistic infections known as fusariosis, ranging from superficial conditions like keratitis and onychomycosis in immunocompetent hosts to severe, often fatal disseminated infections in immunocompromised individuals. Unlike many other pathogenic fungi, members of the Fusarium genus are characterized by high levels of intrinsic resistance to multiple classes of antifungal drugs, including most azoles and echinocandins. Current therapeutic strategies rely primarily on high-dose liposomal amphotericin B and the second-generation triazole voriconazole, which target fungal cell membrane components or sterol biosynthesis pathways. Despite treatment, mortality rates for invasive fusariosis remain exceedingly high, particularly in patients with persistent neutropenia, making the management of these infections a major clinical challenge.

Other names
Fusarium speciesFusariaFusarium spp.Fusarium species complex
02

Mechanism of action

Ergosterol synthesis inhibition via lanosterol 14-alpha-demethylase (CYP51) inhibition; Fungal cell membrane disruption through pore formation; Squalene epoxidase inhibition

03

Biological functions

Fungal growthPathogenesisMycotoxin productionDegradation of ligninBiofilm formation
04

Disease associations

InfectionFusariosisKeratitisOnychomycosisMycotoxicosisEndophthalmitisDisseminated fungal infection
05

Safety considerations

High intrinsic multidrug resistance to common antifungals (azoles, echinocandins)High mortality rates in neutropenic patients (exceeding 80%)Nephrotoxicity and infusion-related reactions associated with systemic amphotericin BDifficulty in differentiating between fungal colonization and invasive infectionPoor response to monotherapy in disseminated cases
06

Interacting drugs

Voriconazole

5 more in the full profile.

07

Biomarkers

1,3-beta-D-glucan (BDG)Translation elongation factor 1-alpha (TEF1a) DNAInternal transcribed spacer (ITS) rDNAFusarium DNA (PCR detection)MALDI-TOF MS fingerprints

Beyond the preview

Go deeper on Fusarium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fusarium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call